Holen Sie sich die Stockscreener-App
2.14
87.72%
1.00
Handel nachbörslich:
2.62
0.48
+22.43%
Schlusskurs vom Vortag:
$1.14
Offen:
$1.18
24-Stunden-Volumen:
22.68M
Relative Volume:
34.09
Marktkapitalisierung:
$36.24M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-10.58M
KGV:
-1.7833
EPS:
-1.2
Netto-Cashflow:
$-9.21M
1W Leistung:
+92.79%
1M Leistung:
+111.88%
6M Leistung:
+103.81%
1J Leistung:
+53.96%
1-Tages-Spanne:
$1.15
$2.25
1-Wochen-Bereich:
$1.08
$2.25
52-Wochen-Spanne:
$0.82
$2.3499
Microbot Medical Inc Stock (MBOT) Company Profile
Firmenname
Microbot Medical Inc
Sektor
Telefon
908-938-5561
Adresse
25 RECREATION PARK DR SUITE 108, HINGHAM, MA
Vergleichen Sie MBOT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MBOT
Microbot Medical Inc
|
2.14 | 36.24M | 0 | -10.58M | -9.21M | -1.20 |
|
ISRG
Intuitive Surgical Inc
|
535.29 | 190.66B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
228.46 | 66.26B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
84.06 | 41.58B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
231.67 | 34.01B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
335.56 | 24.30B | 2.88B | 499.60M | 321.60M | 6.74 |
Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-01-13 | Bestätigt | H.C. Wainwright | Buy |
| 2019-12-24 | Bestätigt | H.C. Wainwright | Buy |
| 2018-01-31 | Eingeleitet | Ladenburg Thalmann | Buy |
Microbot Medical Inc Aktie (MBOT) Neueste Nachrichten
Another Robotics Stock on the Move; Microbot Medical Inc. (Nasdaq: MBOT) - Investorideas.com newswire
Symbol Lookup - GuruFocus.com
Comparing Inspire Medical Systems (NYSE:INSP) and Microbot Medical (NASDAQ:MBOT) - Defense World
Microbot Medical anticipates launch of LIBERTY in Q2 in the U.S. - TipRanks
Microbot Medical Advances with LIBERTY System Milestones - TipRanks
Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY® - The Manila Times
Microbot Medical® Concludes 2024 by Achieving Key - GlobeNewswire
Microbot Medical Submits FDA 510(k) for Revolutionary LIBERTY Endovascular Robotic System, Eyes Q2 2025 Launch - StockTitan
Microbot Medical (NASDAQ:MBOT) Stock Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World
MBOT Stock Gains Following FDA Submission of the LIBERTY System - MSN
Microbot Medical appoints new director and committee member By Investing.com - Investing.com Australia
Microbot Medical appoints new director and committee member - Investing.com
Microbot Medical Stockholders Approve Key Proposals in 2024 - TipRanks
Palm-Sized Innovation: How Microbot Medical Is Helping Redefine Surgical Robotics - Nasdaq
Advanced Robotics Are Reshaping Medicine - Nasdaq
Revolutionary Robotic Surgery System Set for FDA Review! Is the Future Here? - Robots Rising
Microbot Medical submits LIBERTY surgical robot to FDA for approval - Robot Report
Microbot Medical Submits FDA 510(k) Premarket Notification for LIBERTY ® Endovascular Robotic System - Defense World
Microbot Medical Inc. Announces FDA Submission for the Commercialization of the LIBERTY Endovascular Robotic System - Marketscreener.com
Microbot Medical seeks FDA clearance for endovascular robotic system - Yahoo! Voices
Microbot Medical announces US FDA submission for commercialisation of Liberty endovascular robotic system - Vascular News
Microbot Medical Submits 510(k) for Liberty Surgical Robot to FDA - MPO-mag
Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access - The Bakersfield Californian
Microbot Medical's Revolutionary Disposable Robotic Surgery System Awaits FDA Decision - StockTitan
Microbot Medical Advances with LIBERTY® FDA Submission - TipRanks
Microbot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic System - The Manila Times
Microbot Medical® Announces FDA Submission for the - GlobeNewswire
Microbot Medical Files FDA Application for Revolutionary Disposable Robotic Surgery System - StockTitan
Microbot Medical (STU:CY9D) EV-to-Revenue : (As of Dec. 05, 2024) - GuruFocus.com
MBOT (Microbot Medical) EPS without NRI : $-0.80 (TTM As of Sep. 2024) - GuruFocus.com
Microbot Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Microbot Medical (MBOT) Stock Price, News & Analysis - MarketBeat
Microbot Medical’s Liberty Robot Study Draws to a Close - MPO-mag
Microbot Medical Releases Investor Presentation Materials - TipRanks
Yoav Zvi Waizer Net Worth (2024) - GuruFocus.com
Microbot Medical LIBERTY System Trial Advancing Faster Than Expected - MPO-mag
Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025 - MSN
Microbot Medical Stock Rises After Completing ACCESS-PVI Trial - Yahoo Finance
Market Update: Microbot Medical Inc (MBOT) Sees Positive Movement, Closing at 0.96 - The Dwinnex
Microbot Medical completes key clinical trial, eyes FDA submission By Investing.com - Investing.com Australia
CMR Surgical wins FDA nod for surgical robot Versius - Medical Device Network
Microbot eyes FDA application for surgical robot after completing pivotal trial - Medical Device Network
Microbot Medical completes enrolment for ACCESS-PVI clinical trial - Vascular News
Microbot Medical completes key clinical trial, eyes FDA submission - Investing.com
Microbot Medical Advances Towards FDA Submission and Market Entry - TipRanks
Microbot Medical Announces the Successful Completion of its - GlobeNewswire
Microbot Medical faces Nasdaq delisting over share price - Investing.com India
Microbot Medical faces Nasdaq delisting over share price By Investing.com - Investing.com South Africa
Microbot Medical nears end of pivotal clinical trial - Investing.com
Microbot shifts pivotal trial up a gear with completion expected ahead of schedule - Medical Device Network
Microbot Medical Nears FDA Submission with Clinical Advances - TipRanks
Finanzdaten der Microbot Medical Inc-Aktie (MBOT)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.64%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):